{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:40:30Z","timestamp":1774878030169,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ejogrb.2012.01.026","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T04:23:30Z","timestamp":1331007810000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?"],"prefix":"10.1016","volume":"162","author":[{"given":"Magdalena","family":"Olszanecka-Glinianowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Madej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz","family":"Zdun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Bo\u017centowicz-Wikarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Chudek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Ska\u0142ba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2012.01.026_bib0005","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.fertnstert.2005.10.054","article-title":"Obesity and androgens: facts and perspectives","volume":"85","author":"Pasquali","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0010","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0015","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","article-title":"Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome","volume":"16","author":"Kirchengast","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0020","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000151396","article-title":"Expression of adiponectin and adiponectin receptors in human pituitary gland and brain","volume":"89","author":"Psilopanagiotio","year":"2009","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejogrb.2010.08.022","article-title":"Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome","volume":"154","author":"Olszanecka-Glinianowicz","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0030","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effect of insulin","volume":"307","author":"Fukuhara","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0035","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2337\/diabetes.54.10.2911","article-title":"Plasma visfatin concentrations and fat depot-specific mRNA expression in humans","volume":"54","author":"Berndt","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0040","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.metabol.2007.04.007","article-title":"Serum concentration of visfatin in obese women","volume":"56","author":"Zahorska-Markiewicz","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0045","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/joe.1.06211","article-title":"Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes","volume":"185","author":"Kralisch","year":"2005","journal-title":"J Endocrinol"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0050","first-page":"802","article-title":"Plasma visfatin and tumor necrosis factor-alpha (TNF-\u03b1) levels in metabolic syndrome","volume":"69","author":"Olszanecka-Glinianowicz","year":"2011","journal-title":"Pol Heart J"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0055","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/humrep\/dem118","article-title":"Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome","volume":"22","author":"Kowalska","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/09513590802585613","article-title":"Plasma visfatin level in lean women in PCOS: relation to proinflammatory markers and insulin resistance","volume":"25","author":"Gen","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0065","first-page":"425","article-title":"Plasma visfatin level in women with polycystic ovary syndrome","volume":"27","author":"Dikmen","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0070","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.rbmo.2009.10.016","article-title":"Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS","volume":"20","author":"Yildiz","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0075","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.fertnstert.2006.11.120","article-title":"Increased plasma visfatin concentrations in women with polycystic ovary syndrome","volume":"88","author":"Chan","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0080","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nm0106-30","article-title":"RBP4, an unexpected adipokine","volume":"12","author":"Tamori","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0090","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa054862","article-title":"Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects","volume":"354","author":"Graham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0095","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2337\/dc06-0360","article-title":"Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes","volume":"29","author":"Cho","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0100","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1210\/jc.2006-1839","article-title":"Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects","volume":"92","author":"Haider","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0105","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.fertnstert.2008.10.039","article-title":"Serum retinol-binding protein 4 levels in non-obese women with polycystic ovary syndrome","volume":"93","author":"Chan","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0110","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/BF03345631","article-title":"Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome","volume":"31","author":"Diamanti-Kandarakis","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0115","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2337\/dc07-2265","article-title":"Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome","volume":"31","author":"Hutchison","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0120","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1210\/jc.2007-2759","article-title":"Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition","volume":"93","author":"Barber","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1530\/EJE-07-0143","article-title":"Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism","volume":"157","author":"Hahn","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-006-0006-3","article-title":"Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome","volume":"30","author":"Weiping","year":"2006","journal-title":"Endocrine"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0135","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1530\/EJE-07-0833","article-title":"Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome","volume":"158","author":"M\u00f6hlig","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0140","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1210\/jc.2007-0091","article-title":"Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids","volume":"92","author":"Tan","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejogrb.2012.01.026_bib0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211512000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211512000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:26:32Z","timestamp":1759555592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211512000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0301211512000814"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2012.01.026","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2012.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}